Open AccessLong-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major
Author(s) -
Raffaele Nuzzi,
Giada Geronazzo,
F Tridico,
Alessia Nuzzi,
Paolo Caselgrandi,
Antonio Piga
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s300974
Subject(s) - medicine , ophthalmology , glaucoma , deferasirox , chelation therapy , intraocular pressure , nerve fiber layer , visual acuity , fundus (uterus) , thalassemia , retinal , deferiprone , prospective cohort study
The aim of this study is to evaluate eye structures and function in patients receiving iron chelating therapy and to assess whether a correlation exists between the onset of ocular alterations and the intake of iron chelating drugs.